Mather Group’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$54.7K Buy
2,772
+2,764
+34,550% +$56.7K ﹤0.01% 1144
2026
Q2
$156 Hold
8
– – ﹤0.01% 1870
2026
Q1
$154 Buy
+8
New +$158 ﹤0.01% 1859
2025
Q4
– Sell
-14
Closed -$261 – 1463
2025
Q3
$261 Buy
+14
New +$261 ﹤0.01% 1658
2025
Q2
– Sell
-14
Closed -$245 – 1511
2025
Q1
$245 Hold
14
– – ﹤0.01% 1718
2024
Q4
$242 Hold
14
– – ﹤0.01% 1692
2024
Q3
$261 Sell
14
-1,698
-99% -$28.6K ﹤0.01% 1645
2024
Q2
$25.3K Hold
1,712
– – ﹤0.01% 1208
2024
Q1
$24.4K Buy
+1,712
New +$23.7K ﹤0.01% 1018

Other funds holding SBRA

Mather Group's SBRA Position: Q3 2026 in Review

Mather Group increased its Sabra Healthcare REIT (SBRA) stake by 34,550% in Q3 2026, buying an estimated $56.7K and bringing the position to 2,772 shares worth $54.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1144.

Mather Group first reported a position in SBRA in Q1 2024 and has held it in 9 quarters since. 68 funds tracked by Wall St. Rank hold SBRA as of Q3 2026.

  • Mather Group held 2,772 shares of Sabra Healthcare REIT worth $54.7K as of Q3 2026.
  • Mather Group bought 2,764 Sabra Healthcare REIT shares in Q3 2026, an estimated $56.7K.
  • Sabra Healthcare REIT made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #1144 holding.
  • Mather Group first reported a position in Sabra Healthcare REIT in Q1 2024 and has held it in 9 quarters since.
  • 68 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.